RNA–Protein interactions for RNA: ENST00000601733.1

EGLN2-217, Transcript of egl-9 family hypoxia inducible factor 2, humanhuman

TSL 4

Gene EGLN2, Length 584 nt, Biotype protein coding.

Download Table  
RNA Protein Prediction (catRAPID) Interaction (ENCODE eCLIP)
Transcript Symbol Ensembl Transcript ID Gene UniProt Accession Length Protein Status Prediction Score Prediction z-Score p-Value Fold Change
EGLN2-217ENST00000601733 MRPL20Q9BYC9 149 aaKnown RBP13.47□□□□□ -0.25
EGLN2-217ENST00000601733 RAB29O14966 203 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 BET1O15155 118 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 MOSP00540 346 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 NAT1P18440 290 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 TNFSF8P32971 234 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 LSAMPQ13449 338 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 C5orf56Q8N8D9 126 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 OR8H1Q8NGG4 311 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 OR10J5Q8NHC4 309 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 DIRAS2Q96HU8 199 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 ABHD14BQ96IU4 210 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 S1PR3Q99500 378 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 NABP2Q9BQ15 211 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 SCPEP1Q9HB40 452 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 PLSCR3Q9NRY6 295 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 RDH8Q9NYR8 311 aa13.46□□□□□ -0.25
EGLN2-217ENST00000601733 DNAH7Q8WXX0 4024 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 TCRBV4S1A1TA0A5B7 111 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 FCER2P06734 321 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 RPL39P5Q59GN2 51 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 H1FOOQ8IZA3 346 aaPredicted RBP13.45□□□□□ -0.26
EGLN2-217ENST00000601733 LINC00482Q8N8I6 264 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 SOSTQ9BQB4 213 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 RNF150Q9ULK6 438 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 STAB2Q8WWQ8 2551 aa13.45□□□□□ -0.26
EGLN2-217ENST00000601733 TENM2Q9NT68 2774 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 SULT1C2O00338 296 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 PROP1O75360 226 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 CTXN2P0C2S0 81 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 CT45A6P0DMU7 189 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 CT45A5P0DMU8 189 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 CT45A7P0DMV0 189 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 ETV3LQ6ZN32 361 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 LYSMD2Q8IV50 215 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 Q8N9W7 124 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 IFT46Q9NQC8 304 aa13.44□□□□□ -0.26
EGLN2-217ENST00000601733 TSSC4Q9Y5U2 329 aaPredicted RBP13.44□□□□□ -0.26
EGLN2-217ENST00000601733 NCBP2LA6PVI3 153 aaKnown RBP13.43□□□□□ -0.26
EGLN2-217ENST00000601733 F2RL1P55085 397 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 C9orf152Q5JTZ5 239 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 OR5AP2Q8NGF4 316 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 OR52I2Q8NH67 350 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 C15orf40Q8WUR7 153 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 RITA1Q96K30 269 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 GINS4Q9BRT9 223 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 GAB2Q9UQC2 676 aa13.43□□□□□ -0.26
EGLN2-217ENST00000601733 ARPC4P59998 168 aa13.42□□□□□ -0.26
EGLN2-217ENST00000601733 PYHIN1Q6K0P9 492 aa13.42□□□□□ -0.26
EGLN2-217ENST00000601733 CENPVQ7Z7K6 275 aaPredicted RBP13.42□□□□□ -0.26
EGLN2-217ENST00000601733 ZNF436-AS1Q8NC38 126 aaPredicted RBP13.42□□□□□ -0.26
EGLN2-217ENST00000601733 LIN7CQ9NUP9 197 aaKnown RBP13.42□□□□□ -0.26
EGLN2-217ENST00000601733 RABL2AQ9UBK7 228 aaPredicted RBP13.42□□□□□ -0.26
EGLN2-217ENST00000601733 KLK11Q9UBX7 282 aa13.42□□□□□ -0.26
EGLN2-217ENST00000601733 ZNF221Q9UK13 617 aa13.42□□□□□ -0.26
EGLN2-217ENST00000601733 RABL2BQ9UNT1 228 aa13.42□□□□□ -0.26
EGLN2-217ENST00000601733 CTDSPLO15194 276 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 TUSC2O75896 110 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 DUS4LO95620 317 aaKnown RBP13.41□□□□□ -0.26
EGLN2-217ENST00000601733 OR8U9P0C7N5 309 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 NFYAP23511 347 aaPredicted RBP13.41□□□□□ -0.26
EGLN2-217ENST00000601733 MC5RP33032 325 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 GPR12P47775 334 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 DGCR2P98153 550 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 IL18Q14116 193 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 RNASE12Q5GAN4 147 aaKnown RBP13.41□□□□□ -0.26
EGLN2-217ENST00000601733 GLDNQ6ZMI3 551 aaPredicted RBP13.41□□□□□ -0.26
EGLN2-217ENST00000601733 CCDC190Q86UF4 302 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 MRPL41Q8IXM3 137 aaKnown RBP13.41□□□□□ -0.26
EGLN2-217ENST00000601733 FAM71E2Q8N5Q1 922 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 OR5AN1Q8NGI8 311 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 OR6Q1Q8NGQ2 317 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 OR8U1Q8NH10 309 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 BATF3Q9NR55 127 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 MTFP1Q9UDX5 166 aa13.41□□□□□ -0.26
EGLN2-217ENST00000601733 FABP12A6NFH5 140 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 OR5H14A6NHG9 310 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 H0YJW9 148 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 GABARAPH6UMI1 98 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 IGHG2P01859 326 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 OR5H8P0DN80 308 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 S100A5P33763 92 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 RCVRNP35243 200 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 ACTBP60709 375 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 MRPS10P82664 201 aaKnown RBP13.4□□□□□ -0.26
EGLN2-217ENST00000601733 CDK10Q15131 360 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 KHDC1LQ5JSQ8 128 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 FAM131AQ6UXB0 335 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 C18orf65Q6ZTR6 163 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 OVCH2Q7RTZ1 564 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 DRAXINQ8NBI3 349 aaPredicted RBP13.4□□□□□ -0.26
EGLN2-217ENST00000601733 FCAMRQ8WWV6 532 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 OR2W1Q9Y3N9 320 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 V9GYH0 126 aa13.4□□□□□ -0.26
EGLN2-217ENST00000601733 LINC01548A6NM66 108 aa13.39□□□□□ -0.27
EGLN2-217ENST00000601733 PMP2P02689 132 aa13.39□□□□□ -0.27
EGLN2-217ENST00000601733 CNTFRP26992 372 aa13.39□□□□□ -0.27
EGLN2-217ENST00000601733 HLA-DMAP28067 261 aa13.39□□□□□ -0.27
EGLN2-217ENST00000601733 LINC00205P59089 165 aa13.39□□□□□ -0.27
EGLN2-217ENST00000601733 CNPY1Q3B7I2 92 aa13.39□□□□□ -0.27
Retrieved 100 of 20,778 RNA–protein pairs in 34.2 ms